Table 1 Top ranked genes from MAGeCK analysis.

From: Genome-scale CRISPR/Cas9 screen determines factors modulating sensitivity to ProTide NUC-1031

MAGeCK rank

gemcitabine

NUC-1031

Negative selection

Positive selection

Negative selection

Positive selection

Day 14

Day 21

Day 14

Day 21

Day 14

Day 21

Day 14

Day 21

1

CSF3R

NAA10

PP1R32

TSC2

TSC2

hsa-mir-555

TMEM165

TMEM165

2

LRRC24

POLR2D

hsa-mir-4711

CRYGC

ZBTB46

TSC2

DCK

DCK

3

POLB

PELO

NCOA3

ATRNL1

TSC1

DMPK

PYCR2

NTC_0397

4

MBLAC2

RPL14

CENPE

SH3BP4

ZNF281

PCOLCE

DCTPP1

SIRPD

5

NPBWR1

HPS5

UGGT2

hsa-mir-6727

COL4A1

OR10A5

SYNCRIP

TSPAN12

6

COG7

HM13

ARL1

MAP4K5

DDIT4

RUFY1

NTC_0731

HCN3

7

CTTNBP2

WDR43

hsa-mir-548h-5

hsa-mir-1254-2

OR51E2

hsa-mir-185

RASSF7

POMP

8

TNFRSF1A

COX5A

UBXN2A

NTC_0555

PHTF1

OR1M1

NACC2

NTC_0203

9

WWP2

XRCC5

NADK2

hsa-mir-1265

ERBB2IP

CCDC42B

NTC_0040

NTC_0045

10

ATP6V1B1

KIAA1239

CLEC19A

CDH29

LHPP

KCNA3

COQ4

DDO

  1. Genes ranked by MAGeCK by either negative selection or positive selection in gemcitabine or NUC-1031 treated cells after d14 and d21 of exposure.